J&J Pushed Risperdal Despite Breast-Growth Risk, Jury Hears
By Matt Fair ( January 29, 2019, 7:24 PM EST) -- As harshly as a man suing over the antipsychotic drug Risperdal may have been bullied as a young boy over breasts he grew after taking it, a Philadelphia jury heard arguments Tuesday that the real bullies were the decision-makers at a Johnson & Johnson subsidiary who allegedly pushed the drug on children despite knowing its risks....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.